Esperion Therapeutics
ESPR
#6722
Rank
ยฃ0.61 B
Marketcap
ยฃ2.40
Share price
0.00%
Change (1 day)
32.59%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2026 (TTM): ยฃ58.75 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are ยฃ0.41 Billion. In 2025 the company made an earning of ยฃ48.18 Million, an increase over its 2024 earnings that were of ยฃ5.67 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) ยฃ58.75 M21.95%
2025 ยฃ48.18 M749.49%
2024 ยฃ5.67 M-104.99%
2023 -ยฃ0.12 Billion-15.03%
2022 -ยฃ0.14 Billion-20.61%
2021 -ยฃ0.17 Billion84.28%
2020 -ยฃ91.35 Million35.75%
2019 -ยฃ67.29 Million-55.71%
2018 -ยฃ0.16 Billion19.57%
2017 -ยฃ0.13 Billion125.39%
2016 -ยฃ56.38 Million51.43%
2015 -ยฃ37.23 Million36.45%
2014 -ยฃ27.29 Million43.55%
2013 -ยฃ19.01 Million145.26%
2012 -ยฃ7.75 Million
2002 -ยฃ22.1 Million-7.81%
2001 -ยฃ23.97 Million15.03%
2000 -ยฃ20.84 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
ยฃ8.00 B 13,240.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ3.89 B 6,395.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-ยฃ0.41 Billion-775.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-ยฃ19.72 Million-132.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
ยฃ0.14 M-99.76%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.29 B 385.70%๐Ÿ‡บ๐Ÿ‡ธ USA